(Phase II Anticancer Drug Trial / Sites: 8 / Subjects: 100 / CT Scans (avg.): 6 / Trial Period: 2 Years / Readers: 2)
・ Protocol development support / Development of various manuals: $15,000
・ Site selection and approval: $6,000
・ Image Quality Control: $66,000
・ Central Review: $100,000
・ Reading System: $51,000
・ Other expenses (data storage, management, etc.): $83,000
* Reader compensation and non-fixed costs are not included. Total expenses may vary depending on trial details and scope. To request an estimate, please download and fill out the application with your details. Estimates can be provided in around one week.